Patents by Inventor Josue Bermudez

Josue Bermudez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200383299
    Abstract: Computer controlled systems and methods of an automated homecage monitoring system predict a state of an animal and of its homecage. The prediction of the state of the animal may be based on a pose estimate of the animal, and at least one sensor input from an at least one sensor. The pose estimate may include a graph of connected nodes, the nodes representing coordinates of the sensor input corresponding to predicted indicia on the animal's body. The animal state may include a behavioral state of an animal, a social state of an animal, a position state of an animal, a sleep state of an animal, and a biological state of an animal. The automated homecage monitoring system may allow for animal state data to be reported for an animal or animals in situ.
    Type: Application
    Filed: June 5, 2020
    Publication date: December 10, 2020
    Inventors: Edgar Josue Bermudez Contreras, Robert James Sutherland, Majid Mohajerani, Surjeet Singh
  • Publication number: 20070153954
    Abstract: The present invention refers to a method for producing a radium target for the production of radionuclides by means of accelerated protons, whereby at least one radium containing material out of an aqueous-organic solution or suspension of such a material is applied by means of a dispersing device on a surface in such a way that the dispersing device and the surface are moving relatively towards each other and that the solvent is removed substantially spontaneously. Further, the invention refers to a radium target that is created in such a way that it may exhibit an activity of up to 1.5 curie. The radium targets according to the present invention serve for the production of the radionuclide 225Ac, which may be used in nuclear medicine in the treatment of cancer, particularly in form of its daughter nuclide 213Bi.
    Type: Application
    Filed: October 30, 2006
    Publication date: July 5, 2007
    Applicant: Actinium Pharmaceuticals, Inc.
    Inventors: Mark Harfensteller, Ernst Huenges, Michael Schilp, Josue Bermudez